Insights into Nkarta's Financial Health and Strategic Developments in Cell Therapy
Aligns with Analyst Revenue Projections, Misses Earnings Predictions
Key Financial Metrics Surpass Previous Year's Figures, Driving Optimism for Upward Revised FY2024 Guidance
Thru | Total | ||
---|---|---|---|
F | -13 | ||
10 | -12 | ||
7 | -7 | ||
F | -6 | ||
F | -5 | ||
3 | -5 | ||
8 | -5 | ||
3 | -5 | ||
6 | -4 | ||
F | -4 |